+44-330-822-4832
+44-330-822-4832Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
In Dr. Lowe’s state-of-the-art “Biomaterials for Translational Research Laboratory”, the research features innovative bionanotechnology, drug delivery, gene therapy, tissue engineering, and biosensor. The research activities include rational design and synthesis of multi-stimuli-responsive polymeric biomaterials including nanogels, branched nanoparticles, hydrogels and thin films; characterizations of the mechanisms by which the designed biopolymers regulate targeted and sustained delivery of drugs, proteins and genes, promote cell growth, and provide biosensing; and in vitro and in vivo studies of the bioefficacy of these biomaterials. The ultimate goal of the research in Dr. Lowe’s lab is to develop novel biomaterials that can provide exquisitely sensitive, selective, non-toxic, biodegradable and responsive platforms to target therapeutic agents to the sites of ocular, central nervous, cancerous and musculoskeletal lesions.
• Bionanotechnology
• Drug delivery
• Gene therapy
• Tissue engineering
• Biosensor
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
